A Study Evaluating the Efficacy and Safety of BOTOX® or Solifenacin in Patients With Overactive Bladder and Urinary Incontinence

NCT01767519 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

356

Enrollment

INDUSTRY

Sponsor class

Conditions

Overactive Bladder
Urinary Incontinence

Interventions

BIOLOGICAL: BOTOX®
DRUG: solifenacin
DRUG: Botox placebo (normal saline)
DRUG: solifenacin placebo

Sponsor

Allergan